Delcath Systems Inc. Registered Shares New DL-,01
- BID
11.23
- ASK
11.35
- 1,781 Units1,762 Units
- 07/21, 16:36:01 PM
Sector and Industry
Healthcare, Biopharmaceuticals
Performance (1Y)
13.30%
Market Cap
-
P/E Ratio
149.41
Dividend Yield
0.00 %
Earnings per Share
0.06 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Eli Lilly and Company | 864.54 Bil. | 57.78 Bil. | 46.82 | +86.88 % | 0.00 | - |
| Johnson & Johnson | 425.70 Bil. | 83.48 Bil. | 18.82 | +82.71 % | 0.00 | - |
| AbbVie Inc. | 343.94 Bil. | 54.21 Bil. | 96.78 | -5.29 % | 0.00 | - |
| Roche Holding AG | 286.62 Bil. | 65.80 Bil. | 20.72 | +58.45 % | 0.00 | - |
| AstraZeneca PLC | 244.91 Bil. | 52.09 Bil. | 27.55 | +39.41 % | 0.00 | - |
| NOVARTIS AG | 224.76 Bil. | 48.44 Bil. | 18.30 | +12.45 % | 0.00 | - |
| Merck & Co. Inc. | 221.79 Bil. | 57.55 Bil. | 14.46 | +2.25 % | 0.00 | - |
| Novo-Nordisk AS B | 193.52 Bil. | 41.49 Bil. | 14.11 | +1.54 % | 0.00 | - |
| Amgen Inc. | 150.16 Bil. | 32.57 Bil. | 23.01 | +80.77 % | 0.00 | - |
| Gilead Sciences Inc. | 129.70 Bil. | 26.10 Bil. | 18.10 | +1,599.93 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 11.22 G | 0 Units |
| PRICE DETERMINATION TIME | 07/21/2026 / 04:33:46 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 11.22 | 10.89 |
| PREV. DAY'S PRICE | 10.99 | (07/20) |
| CHANGE DAY BEFORE | +0.23 | 2.09 % |
| 52 WEEK HIGH / LOW | 12.1 (10/20) | 7.2 (02/27) |
Key Figures (in EUR)
| 2023 | 2024 | 2025 | 2026e | 2027e | |
|---|---|---|---|---|---|
EARNINGS PER SHARE | -2.72 | -0.86 | 0.06 | -0.38 | -0.28 |
DIVIDENDS PER SHARE | 0.00 | 0.00 | 0.00 | - | - |
DIVIDEND YIELD IN % | 0.00 % | 0.00 % | 0.00 % | - | - |
DIVIDEND GROWTH IN % | - | - | - | - | - |
PRICE - EARNINGS RATIO | - | - | 149.41 | - | - |
PRICE - BOOK RATIO | 6.00 | 5.79 | 3.15 | - | - |
PRICE - SALES RATIO | 32.70 | 9.23 | 4.73 | - | - |
PRICE - CASH FLOW RATIO | - | - | 17.91 | - | - |
Master Data
| WKN | A2PT5P |
| ISIN | US24661P8077 |
| SYMBOL | DV3R |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | Delcath Systems |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | - |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Biopharmaceuticals |
| NUMBER OF SHARES | - |
| MARKET CAPITALISATION | - |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | -2.70 % | 9.52 % | 20.11 % | 27.05 % | 13.30 % | 153.23 % | 47.52 % | 29.29 % |
| HIGH | 11.50 | 11.92 | 11.92 | 11.92 | 12.10 | 16.20 | 16.20 | 11.92 |
| LOW | 10.87 | 9.85 | 8.54 | 7.20 | 7.20 | 2.16 | 2.16 | 7.20 |
Dividende
pro Aktie
Delcath Systems does not deliver dividend information
Company profile
Delcath Systems, Inc. is an oncology company, which engages in the treatment of primary and metastatic liver cancers. Its products include CHEMOSAT and HEPZATO. The company was founded on August 5, 1988 and is headquartered in Queensbury, NY.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.